Cargando…
Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis
Myocardial infarction (MI) is the primary cause of cardiovascular mortality, and therapeutic strategies to prevent or mitigate the consequences of MI are a high priority. Cardiac progenitor cells (CPCs) have been used to treat cardiac injury post-MI, and despite poor engraftment, they have been show...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356993/ https://www.ncbi.nlm.nih.gov/pubmed/30634641 http://dx.doi.org/10.3390/antiox8010018 |
_version_ | 1783391687171637248 |
---|---|
author | Youn, Seock-Won Li, Yang Kim, Young-Mee Sudhahar, Varadarajan Abdelsaid, Kareem Kim, Ha Won Liu, Yutao Fulton, David J.R. Ashraf, Muhammad Tang, Yaoliang Fukai, Tohru Ushio-Fukai, Masuko |
author_facet | Youn, Seock-Won Li, Yang Kim, Young-Mee Sudhahar, Varadarajan Abdelsaid, Kareem Kim, Ha Won Liu, Yutao Fulton, David J.R. Ashraf, Muhammad Tang, Yaoliang Fukai, Tohru Ushio-Fukai, Masuko |
author_sort | Youn, Seock-Won |
collection | PubMed |
description | Myocardial infarction (MI) is the primary cause of cardiovascular mortality, and therapeutic strategies to prevent or mitigate the consequences of MI are a high priority. Cardiac progenitor cells (CPCs) have been used to treat cardiac injury post-MI, and despite poor engraftment, they have been shown to inhibit apoptosis and to promote angiogenesis through poorly understood paracrine effects. We previously reported that the direct injection of exosomes derived from CPCs (CPCexo) into mouse hearts provides protection against apoptosis in a model of acute ischemia/reperfusion injury. Moreover, we and others have reported that reactive oxygen species (ROS) derived from NADPH oxidase (NOX) can enhance angiogenesis in endothelial cells (ECs). Here we examined whether bioengineered CPCexo transfected with a pro-angiogenic miR-322 (CPCexo-322) can improve therapeutic efficacy in a mouse model of MI as compared to CPCexo. Systemic administration of CPCexo-322 in mice after ischemic injury provided greater protection post-MI than control CPCexo, in part, through enhanced angiogenesis in the border zones of infarcted hearts. Mechanistically, the treatment of cultured human ECs with CPCexo-322 resulted in a greater angiogenic response, as determined by increased EC migration and capillary tube formation via increased Nox2-derived ROS. Our study reveals that the engineering of CPCexo via microRNA (miR) programing can enhance angiogenesis, and this may be an effective therapeutic strategy for the treatment of ischemic cardiovascular diseases. |
format | Online Article Text |
id | pubmed-6356993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63569932019-02-04 Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis Youn, Seock-Won Li, Yang Kim, Young-Mee Sudhahar, Varadarajan Abdelsaid, Kareem Kim, Ha Won Liu, Yutao Fulton, David J.R. Ashraf, Muhammad Tang, Yaoliang Fukai, Tohru Ushio-Fukai, Masuko Antioxidants (Basel) Article Myocardial infarction (MI) is the primary cause of cardiovascular mortality, and therapeutic strategies to prevent or mitigate the consequences of MI are a high priority. Cardiac progenitor cells (CPCs) have been used to treat cardiac injury post-MI, and despite poor engraftment, they have been shown to inhibit apoptosis and to promote angiogenesis through poorly understood paracrine effects. We previously reported that the direct injection of exosomes derived from CPCs (CPCexo) into mouse hearts provides protection against apoptosis in a model of acute ischemia/reperfusion injury. Moreover, we and others have reported that reactive oxygen species (ROS) derived from NADPH oxidase (NOX) can enhance angiogenesis in endothelial cells (ECs). Here we examined whether bioengineered CPCexo transfected with a pro-angiogenic miR-322 (CPCexo-322) can improve therapeutic efficacy in a mouse model of MI as compared to CPCexo. Systemic administration of CPCexo-322 in mice after ischemic injury provided greater protection post-MI than control CPCexo, in part, through enhanced angiogenesis in the border zones of infarcted hearts. Mechanistically, the treatment of cultured human ECs with CPCexo-322 resulted in a greater angiogenic response, as determined by increased EC migration and capillary tube formation via increased Nox2-derived ROS. Our study reveals that the engineering of CPCexo via microRNA (miR) programing can enhance angiogenesis, and this may be an effective therapeutic strategy for the treatment of ischemic cardiovascular diseases. MDPI 2019-01-10 /pmc/articles/PMC6356993/ /pubmed/30634641 http://dx.doi.org/10.3390/antiox8010018 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Youn, Seock-Won Li, Yang Kim, Young-Mee Sudhahar, Varadarajan Abdelsaid, Kareem Kim, Ha Won Liu, Yutao Fulton, David J.R. Ashraf, Muhammad Tang, Yaoliang Fukai, Tohru Ushio-Fukai, Masuko Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title_full | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title_fullStr | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title_full_unstemmed | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title_short | Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis |
title_sort | modification of cardiac progenitor cell-derived exosomes by mir-322 provides protection against myocardial infarction through nox2-dependent angiogenesis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356993/ https://www.ncbi.nlm.nih.gov/pubmed/30634641 http://dx.doi.org/10.3390/antiox8010018 |
work_keys_str_mv | AT younseockwon modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT liyang modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT kimyoungmee modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT sudhaharvaradarajan modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT abdelsaidkareem modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT kimhawon modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT liuyutao modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT fultondavidjr modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT ashrafmuhammad modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT tangyaoliang modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT fukaitohru modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis AT ushiofukaimasuko modificationofcardiacprogenitorcellderivedexosomesbymir322providesprotectionagainstmyocardialinfarctionthroughnox2dependentangiogenesis |